分析淋巴結(jié)可有效預(yù)測大腸癌復(fù)發(fā)幾率(2)
2011-02-16 17:40
閱讀:2388
來源:愛愛醫(yī)編輯部
作者:水**南
責(zé)任編輯:水北天南
[導(dǎo)讀] 根據(jù)杰弗遜金梅爾癌癥中心研究人員2月9日在《臨床癌癥研究》上公布了一項新研究表明,定量、分子分析患者淋巴結(jié)可以有效預(yù)測大腸癌的復(fù)發(fā)幾率
愛愛醫(yī)推薦原文閱讀:
A quantitative, molecular **ysis of lymph nodes in patients deemed colorectal cancer-free was found to be an effective predictor of recurrence, according to a study from researchers at the Kimmel Cancer Center at Jefferson and published online Feb 9. in Clinical Cancer Research.
Recurrence occurs in about 25 percent of node-negative patients (pN0), suggesting that occult metastases escaped detection, be it imaging modalities or histopathology.
To better predict recurrence and accurately stage these patients, Terry Hyslop, Ph.D. and Scott A. Waldman, M.D., Ph.D. of the Department of Pharmacology and Experimental Therapeutics of Thomas Jefferson University and the Kimmel Cancer Center at Jefferson, and colleagues explored a novel molecular approach, using the biomarker GUCY2C for metastatic colorectal cancer cells.
Using 291 colorectal cancer patients who were node-negative, the researchers **yzed lymph nodes by histopathology and GUCY2C quantitative qRT-PCR. They were followed for a median of 24 months and categorized as having either low, intermediate or high tumor burdens.
版權(quán)聲明:
本站所注明來源為"愛愛醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個人可與我們
聯(lián)系zlzs@120.net,我們將立即進行刪除處理